Price range: $513.99 through $594.99
Description
Mounjaro KwikPen is an injectable medication used to help adults with type 2 diabetes control their blood sugar levels. It contains tirzepatide, a medicine that helps regulate blood sugar and supports weight loss when combined with diet and exercise.
Key features
- Dual action: Works by stimulating insulin release and reducing appetite.
- Easy-to-use pen: Pre-filled, ready to inject with adjustable doses.
- Once-weekly injection: Convenient dosing to help maintain blood sugar control.
Benefits
- Improves blood sugar levels
- Supports weight loss
- Simple, quick injections at home
- Can be used with other diabetes medications
Ingredients
- Tirzepatide (dose varies)
- Other inactive ingredients to stabilise the solution
Package content
One pre-filled, disposable KwikPen with multiple doses
Specifications
- Main Ingredient:
- Manufacturer: Eli Lilly and Company
- Drug Class:
- Generic Name: Tirzepatide
- Package Contents: One pre-filled, disposable KwikPen
- Storage Requirements: Refrigerated between 2°C – 8°C
- Main Usage: Weight Loss, Diabetes
Here to help
Questions about ordering, delivery or products? You can email our team here or call now at 1-800-630-9757 and be connected with your dedicated Account Manager
Related Products
RejuvaNAD+
Powerfill®
Related Articles
Neuramis Filler – Professional Anti-Aging Injectable
The global dermal filler market has experienced consistent growth, with industry reports valuing it at…
Types of Gel Injections for Knees: Pain Relief Options
Knee pain affects over 1 in 4 adults in the United States, and it’s one…
Rejuran Skin Booster – Advanced Skin Renewal Therapy
Skin aging is an inevitable biological process that is accelerated by environmental stressors, lifestyle factors,…
Nexplanon Implant | Modern Contraception Made Simple
According to the Guttmacher Institute, more than 65% of U.S. women of reproductive age currently…
What Are PDO Threads and How Do They Work?
Thread-based rejuvenation techniques have gained remarkable popularity in aesthetic medicine as a minimally invasive solution…
Hymovis Injection: Relief from Knee Joint Discomfort
Osteoarthritis is one of the major causes of disability worldwide, affecting more than 32.5 million…
Supartz vs Euflexxa – Which Is Best for Joint Pain?
According to the Centers for Disease Control and Prevention (CDC), around 32 million adults in…
Anti-Aging with Peptides for Skin: What to Know
The global anti-aging market is projected to exceed $120 billion by 2030, reflecting a steady…

